Skip to main content
. 2021 Dec 24;12(5):2417–2428. doi: 10.1016/j.apsb.2021.12.013

Figure 7.

Figure 7

In vitro activity determination of 3 gsADCs against two HER2 positive tumor cell lines, SK-Br-3 (A) and NCI-N87 (B), and HER2 negative tumor cell line MDA-MB-231 (C).